The Cannabinoid Medicine Observational Study (CMOS) intends to collect data from 20,000 patients across the country. The study will observe how patients with a variety of illness and conditions react to medicinal cannabis.
The Cannabinoid Medicine Observational Study (CMOS) intends to collect data from 20,000 patients across the country. The study will observe how patients with a variety of illness and conditions react to medicinal cannabis.